← Eichor
Condition: Postoperative Adjuvant Treatment Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Postoperative Adjuvant Treatment

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Phase 4 · 34 location(s) · Fudan University · NCT04790305Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
NA · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT07180901Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC
Phase 2 · 1 location(s) · Hunan Cancer Hospital · NCT06752798Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
Phase 2 · 1 location(s) · Zhejiang Provincial People's Hospital · NCT06722911Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06727617Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surge
Phase 2 · 4 location(s) · University of Chicago · NCT06348134Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC
Phase N/A · 2 location(s) · Peking University First Hospital · NCT06598761Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
Phase 2 · 20 location(s) · UNICANCER · NCT05973864Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Canc
Phase 3 · 33 location(s) · M.D. Anderson Cancer Center · NCT03583710Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · 356 location(s) · Gilead Sciences · NCT05633654Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
Phase 2 · 3 location(s) · Olgun Elicin · NCT07058805Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC
Phase 2/Phase 3 · 1 location(s) · Second Affiliated Hospital of Wenzhou Medical University · NCT06341907ProLARS Trial: Prospective Longitudinal Follow-up of Low Anterior Resection Syndrome (LARS) and COREFO Score After Rectu
NA · 1 location(s) · University Hospital, Antwerp · NCT07339904Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer
NA · 1 location(s) · Peking Union Medical College Hospital · NCT05424692Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients
Phase 2 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT05825443Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subje
Phase 3 · 179 location(s) · Greenwich LifeSciences, Inc. · NCT05232916Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-smal
Phase 2/Phase 3 · 1 location(s) · Kong Fanming · NCT07034326Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
NA · 4 location(s) · Medical University of South Carolina · NCT05793151Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
NA · 1 location(s) · Peking University People's Hospital · NCT06930807Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
Phase 2 · 1 location(s) · Jiangxi Provincial Cancer Hospital · NCT05252078Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinom
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07417800Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06761846De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas
NA · 10 location(s) · Technische Universität Dresden · NCT03396718Safety and Efficacy of IMPT or IMRT for Breast Cancer
Phase N/A · 1 location(s) · Ruijin Hospital · NCT06826885Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lu
Phase 2 · 21 location(s) · Fundación GECP · NCT07153445Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal
Phase 2 · 140 location(s) · ECOG-ACRIN Cancer Research Group · NCT03493425Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma
NA · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06581315Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer
NA · 1 location(s) · Ruijin Hospital · NCT07527689MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer
NA · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07156058PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05430698
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.